ANVISA recently published Resolution No. 576/2021 with the aim of simplifying the notification procedure for low-risk drugs.
Marianne Albers and Thais Fernandes have written an Alert, in Portuguese, explaining in detail how the new notification process works.
Read more at: https://bit.ly/3HDcCaj
